Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric Cancer Third Line”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)UnknownNCT02662959
What this trial is testing

Irinotecan as 3rd Line Therapy in Gastric Cancer

Who this might be right for
Stomach Neoplasms
Fudan University 93
Testing effectiveness (Phase 2)UnknownNCT06437678
What this trial is testing

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 50
Large-scale testing (Phase 3)Study completedNCT00970138
What this trial is testing

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Carcinoma
Fudan University 141
Testing effectiveness (Phase 2)UnknownNCT05095636
What this trial is testing

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Gastric CancerMetastasis
Fudan University 102
Testing effectiveness (Phase 2)UnknownNCT05342389
What this trial is testing

Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 68
Early research (Phase 1)UnknownNCT04508686
What this trial is testing

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)

Who this might be right for
Advanced Cervical Cancer
Ruijin Hospital 20
Large-scale testing (Phase 3)Study completedNCT02625623
What this trial is testing

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Who this might be right for
Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaGastric Cancer Third Line
EMD Serono Research & Development Institute, Inc. 371
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07364422
What this trial is testing

To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer (GC)
Onconic Therapeutics Inc. 49
Not applicableNot Yet RecruitingNCT07371871
What this trial is testing

A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Anhui Provincial Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02435108
What this trial is testing

A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy

Who this might be right for
c-MET Positive Gastric Cancer
Samsung Medical Center 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507526
What this trial is testing

Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
Sun Yat-sen University 76
Large-scale testing (Phase 3)Looking for participantsNCT07270991
What this trial is testing

Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma

Who this might be right for
Metastatic Oesogastric Adenocarcinoma
Federation Francophone de Cancerologie Digestive 324
Testing effectiveness (Phase 2)Active Not RecruitingNCT02485015
What this trial is testing

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
The First People's Hospital of Changzhou 80
Not applicableStudy completedNCT03486379
What this trial is testing

Folfiri as Third Line of Treatment

Who this might be right for
Gastric CancerRamucirumabThird Line
IRCCS Cancer Referral Center of Basilicata 26
Testing effectiveness (Phase 2)Looking for participantsNCT06711471
What this trial is testing

Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer

Who this might be right for
Gastric Cancer Adenocarcinoma Metastatic
LIN YANG 31
Testing effectiveness (Phase 2)Study completedNCT01576380
What this trial is testing

A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

Who this might be right for
Adenocarcinoma, ScirrhousLinitis PlasticaStomach Neoplasms+3 more
Novartis Pharmaceuticals 11